ProShares UltraShort Health Care
3 hedge funds and large institutions have $175K invested in ProShares UltraShort Health Care in 2024 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 0 closing their positions.
370% more capital invested
Capital invested by funds: $37.1K → $175K (+$138K)
50% more funds holding
Funds holding: 2 → 3 (+1)
5.47% more ownership
Funds ownership: 2.21% → 7.68% (+5.5%)
23% less call options, than puts
Call options by funds: $8.35M | Put options by funds: $10.9M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$120K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$26.6K |
Top Sellers
RXD Hedge Fund Activity: Q3 2024 in Review
3 of the 6,977 institutional investors tracked by Wall St. Rank reported a position in ProShares UltraShort Health Care (RXD) for Q3 2024, worth a combined $175K — up 370% from $37.1K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new RXD positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 0 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $120K.
- 3 institutional investors held ProShares UltraShort Health Care (RXD) as of Q3 2024, up from 2 in Q2 2024.
- Funds reported $175K of ProShares UltraShort Health Care stock for Q3 2024, up 370% quarter-over-quarter.
- 1 fund opened new ProShares UltraShort Health Care positions in Q3 2024 and 0 closed out, a net change of +1 holder.
- The largest ProShares UltraShort Health Care buyer in Q3 2024 was Susquehanna International Group, an estimated $120K added.
Based on aggregated 13F filings for Q3 2024.